CICI
NVO

Capital Investment Counsel Inc’s Novo Nordisk NVO Stock Holding History

Capital Investment Counsel Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,630
Closed -$201K – 268
2025
Q3 		$201K Sell
3,630
-970
-21% -$56.8K 0.02% 194
2025
Q2 		$317K Buy
4,600
+100
+2% +$6.8K 0.04% 152
2025
Q1 		$312K Hold
4,500
– – 0.05% 151
2024
Q4 		$387K Sell
4,500
-1,400
-24% -$151K 0.06% 129
2024
Q3 		$703K Hold
5,900
– – 0.1% 99
2024
Q2 		$842K Buy
5,900
+200
+4% +$26.5K 0.13% 91
2024
Q1 		$732K Hold
5,700
– – 0.13% 91
2023
Q4 		$590K Hold
5,700
– – 0.1% 100
2023
Q3 		$518K Hold
5,700
– – 0.1% 102
2023
Q2 		$461K Hold
5,700
– – 0.09% 110
2023
Q1 		$454K Hold
5,700
– – 0.1% 106
2022
Q4 		$386K Buy
+5,700
New +$334K 0.09% 119
2022
Q3 		– Sell
-5,900
Closed -$329K – 190
2022
Q2 		$329K Buy
5,900
+600
+11% +$33.3K 0.08% 126
2022
Q1 		$294K Hold
5,300
– – 0.06% 144
2021
Q4 		$297K Buy
5,300
+500
+10% +$27.1K 0.06% 150
2021
Q3 		$230K Hold
4,800
– – 0.05% 148
2021
Q2 		$201K Buy
+4,800
New +$186K 0.04% 165
2019
Q2 		– Sell
-11,600
Closed -$303K – 171
2019
Q1 		$303K Sell
11,600
-2,000
-15% -$49.2K 0.11% 117
2018
Q4 		$313K Hold
13,600
– – 0.14% 102
2018
Q3 		$321K Sell
13,600
-3,000
-18% -$73.2K 0.12% 108
2018
Q2 		$383K Hold
16,600
– – 0.15% 97
2018
Q1 		$409K Sell
16,600
-320
-2% -$8.4K 0.17% 93
2017
Q4 		$454K Hold
16,920
– – 0.19% 92
2017
Q3 		$407K Sell
16,920
-2,000
-11% -$45.2K 0.18% 94
2017
Q2 		$406K Sell
18,920
-4,000
-17% -$80.7K 0.18% 95
2017
Q1 		$393K Buy
+22,920
New +$399K 0.18% 93

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Investment Counsel Inc's NVO Position: Q4 2025 in Review

Capital Investment Counsel Inc sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,630 shares — an estimated $201K sold.

Capital Investment Counsel Inc first reported a position in NVO in Q1 2017 and held it in 26 quarters. The position peaked at $842K in Q2 2024. 1,415 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Capital Investment Counsel Inc reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Capital Investment Counsel Inc sold 3,630 Novo Nordisk shares in Q4 2025, an estimated $201K.
  • Capital Investment Counsel Inc first reported a position in Novo Nordisk in Q1 2017 and held it in 26 quarters.
  • Capital Investment Counsel Inc's Novo Nordisk position peaked at $842K in Q2 2024.
  • 1,415 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Capital Investment Counsel Inc's 13F filing for Q4 2025, filed 23 Jan 2026.